EMVision wins $3m grant to expand scanner into traumatic brain injury

Resumen detallado
A $3 million non-dilutive CRC-P grant is awarded to develop and clinically test a First Responder brain scanner for traumatic ... Read More The post EMVision wins $3m grant to…
EMV is set to expand indications for its First Responder into TBI after a grant boost. Pic: Getty Images
Special Report: EMVision Medical Devices is expanding the potential applications of its First Responder portable brain scanner beyond stroke detection, winning a $3 million government grant to investigate its use in traumatic brain injury (TBI).
The non-dilutive Cooperative Research Centres Projects (CRC-P) grant will fund development and preliminary clinical validation of First Responder for assessing suspected TBI.
EMVision Medical Devices (ASX:EMV) said the central focus would be on detecting traumatic intracranial haemorrhage (tICH).
The project will involve adapting EMV’s portable, non-ionising First Responder brain scanner and diagnostic algorithms for TBI, with the aim of generating preliminary evidence of its diagnostic performance.
Clinical data will be collected from suspected TBI patients in emergency departments, alongside paired scans using CT or MRI as reference imaging to train and test the haemorrhage detection algorithms.
The project will include human factors and safety evaluations of the First Responder in emergency settings, as well as preliminary validation of its sensitivity and specificity in detecting traumatic intracranial haemorrhage.
The findings will provide a foundation for subsequent clinical studies to support regulatory clearance for a TBI indication.
The research will also explore whether the device could help assess concussion. There is no objective diagnostic test for concussion in routine use with diagnosis relying on clinical assessment of symptoms.
Inicio del artículo, extracto de Stockhead. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stockhead.com.au)




